Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CTLA4
Pharma
ASCO: Bristol calls Roche and AZ's bets in 1L liver cancer
Bristol Myers Squibb's immunotherapy combination broke AstraZeneca's three-year overall survival rate record in newly diagnosed liver cancer.
Angus Liu
Jun 4, 2024 8:00am
ASCO: AZ's latest Tagrisso data receive standing ovation
Jun 3, 2024 7:37am
Regeneron's Libtayo delivers lung cancer win with BMS' Yervoy
Dec 1, 2022 12:25pm
ESMO: Exelixis faces uphill battle with kidney cancer triplet
Sep 12, 2022 10:30am
AZ's R&D chiefs talk roxadustat, Imfinzi-treme
Feb 10, 2022 10:13am
AZ oncology R&D chief marks Imfinzi as 'core backbone'
Jan 20, 2022 2:40pm
